Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China flag China · Delayed Price · Currency is CNY
17.06
+0.21 (1.25%)
Feb 3, 2026, 1:24 PM CST

SHA:603858 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
10,92810,97413,22914,94215,75515,983
Other Revenue
32.0632.0616.629.627.3623.24
10,96011,00613,24514,95115,76316,007
Revenue Growth (YoY)
-6.93%-16.91%-11.41%-5.15%-1.52%12.29%
Cost of Revenue
4,0934,5524,3214,2684,1343,739
Gross Profit
6,8676,4548,92410,68311,62912,268
Selling, General & Admin
5,3735,3337,3658,3879,2379,212
Research & Development
318.83345.41335.08284.12408.6533.42
Other Operating Expenses
116.44120.01181.03232.07226.9234.55
Operating Expenses
5,7695,7737,8898,9079,8889,981
Operating Income
1,098680.711,0351,7761,7412,287
Interest Expense
-123.4-129.59-109.93-135.1-167.29-145.05
Interest & Investment Income
17.0420.5540.1222.6141.3432.9
Currency Exchange Gain (Loss)
0.190.190.080.45-0.120.04
Other Non Operating Income (Expenses)
89.11-3.88-47.33-11.43-6.739.5
EBT Excluding Unusual Items
1,081567.97918.421,6521,6082,184
Impairment of Goodwill
-853.03-853.03-598.03-2,943-10.15-0.24
Gain (Loss) on Sale of Investments
14.34-0.15-2.36-56.79-60-
Gain (Loss) on Sale of Assets
-1.9-1.62-2.47-0.66-0.59-0.54
Asset Writedown
19.45-0.25-0.3---
Other Unusual Items
-106.32-78.2179.388.51176.49177.25
Pretax Income
153.44-365.29394.56-1,2591,7142,361
Income Tax Expense
282.58337.1242.69331.59478.29517.55
Earnings From Continuing Operations
-129.14-702.39151.87-1,5911,2351,843
Minority Interest in Earnings
130.8148.6167.1161.2453.8417.75
Net Income
1.66-553.8318.97-1,5301,2891,861
Net Income to Common
1.66-553.8318.97-1,5301,2891,861
Net Income Growth
-----30.72%-4.37%
Shares Outstanding (Basic)
1,0601,0841,1061,1061,1061,106
Shares Outstanding (Diluted)
1,0601,0841,1061,1061,1061,106
Shares Change (YoY)
-3.15%-2.01%-0.00%-0.01%0.01%-0.87%
EPS (Basic)
0.00-0.510.29-1.381.171.68
EPS (Diluted)
0.00-0.510.29-1.381.171.68
EPS Growth
-----30.72%-3.54%
Free Cash Flow
959.86742.96-725.522,212886.981,422
Free Cash Flow Per Share
0.910.69-0.662.000.801.29
Dividend Per Share
0.390-0.1260.9600.3600.526
Dividend Growth
209.52%--86.88%166.67%-31.56%-67.41%
Gross Margin
62.65%58.64%67.38%71.45%73.77%76.64%
Operating Margin
10.02%6.19%7.82%11.88%11.04%14.29%
Profit Margin
0.01%-5.03%2.41%-10.23%8.18%11.63%
Free Cash Flow Margin
8.76%6.75%-5.48%14.80%5.63%8.89%
EBITDA
1,4261,1151,6122,2562,2332,711
EBITDA Margin
13.01%10.13%12.17%15.09%14.17%16.94%
D&A For EBITDA
328.36434.7576.49479.96492.39424.55
EBIT
1,098680.711,0351,7761,7412,287
EBIT Margin
10.02%6.19%7.82%11.88%11.04%14.29%
Effective Tax Rate
184.16%-61.51%-27.91%21.92%
Revenue as Reported
10,96011,00613,24514,95115,76316,007
Advertising Expenses
-27.0841.38---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.